Novel RNA aptamers targeting gastrointestinal cancer biomarkers CEA, CA50 and CA72-4 with superior affinity and specificity.
Gastric cancer is the third most common cause of death from cancer in the world and it remains difficult to cure in Western countries, primarily because most patients present with advanced disease. Currently, CEA, CA50 and CA72-4 are commonly used as tumor markers for gastric cancer by immunoassays....
Main Authors: | Qing Pan, Carmen O K Law, Mingo M H Yung, K C Han, Yuen Lam Pon, Terrence Chi Kong Lau |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6179186?pdf=render |
Similar Items
-
CA72-4 e CEA no soro e no lavado peritonial de doentes com câncer gástrico CA72-4 and CEA in serum and peritoneal washing in gastric cancer
by: Sandra MANDORWSKI, et al.
Published: (2002-03-01) -
Clinical Value of Abnormal Prothrombin Combined with CEA, CA72-4 and CA199 on Patients with Gastric Cancer
by: CAI Xiaojuan, et al.
Published: (2018-06-01) -
Comparison of CYFRA 21-1, CEA, CA 19-9 and CA 72-4 levels in gastric cancer
by: Gökhan Çakırca, et al.
Published: (2013-01-01) -
Clinical Significance and Prognostic Value of CA72-4 Compared with CEA and CA19-9 in Patients with Gastric Cancer
by: M. Ychou, et al.
Published: (2000-01-01) -
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer
by: Yanfeng Gao, et al.
Published: (2018-02-01)